This led to 2 novel findings: i) the functional and pathway analyses suggested that metastasis-related biological processes may already be highly expressed even in the early stage of gastric cancer, and ii) the gene expression pattern of EGC is closely aligned to that of ERα-negative breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.